AIDOT Co., Ltd. (CEO: Jaehoon Jeong), an AI medical imaging company, participated in The 48th Annual Conference of the Association of Medical Technologists of Thailand (ACMTT 2026) held in Bangkok, Thailand, where it showcased its flagship solution, Cerviray AI, reinforcing its expansion into the Southeast Asian medical AI market.
ACMTT 2026 took place from June 30 to July 1, 2026, at the IMPACT Forum, Muang Thong Thani, Bangkok, Thailand. Organized by the Association of Medical Technologists of Thailand, the annual conference was held under the theme "AI with a Human Touch," highlighting the latest advancements in medical AI, digital healthcare, diagnostic technologies, and laboratory innovation. The event serves as a leading academic and exhibition platform where medical technologists, clinicians, researchers, and healthcare industry professionals from Thailand and across Southeast Asia gather to exchange insights on emerging technologies and clinical applications.
At the conference, AIDOT introduced the core technologies and clinical value of Cerviray AI, conducted live product demonstrations for attendees, and explored various collaboration opportunities with healthcare professionals and potential partners.
Cerviray AI is an AI-powered cervical cancer diagnostic support solution that automatically detects suspicious cervical lesions from cervical images and classifies them into four categories, ranging from Normal to CIN3+. The solution also provides an automatic lesion detection feature that visually highlights suspected lesion locations.
Powered by on-device AI, Cerviray AI can operate without a stable internet connection after the initial login. Patient data is never transmitted to external servers; instead, all data is encrypted and analyzed directly on the device within the healthcare facility, enhancing data security and patient privacy. In addition, on-device AI inference enables fast and efficient diagnostic support.
Through its participation in ACMTT 2026, AIDOT plans to further expand partnerships with healthcare institutions and distributors in Thailand and across Southeast Asia, while accelerating the global adoption of its AI-powered cervical cancer diagnostic support solution.
Korea Economic TV / 2026-06-05 / Deputy Managing Editor Jae-jun Yang
